Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The evolving future of PCSK9 inhibitors
Variants in proprotein convertase subtilisin/kexin type 9 (PCSK9) provide insights into
mechanisms regulating low-density lipoprotein (LDL) levels. Human monoclonal antibodies …
mechanisms regulating low-density lipoprotein (LDL) levels. Human monoclonal antibodies …
[HTML][HTML] There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and …
Atherosclerotic cardiovascular disease (ASCVD) is epidemic throughout the world and is
etiologic for such acute cardiovascular events as myocardial infarction, ischemic stroke …
etiologic for such acute cardiovascular events as myocardial infarction, ischemic stroke …
[HTML][HTML] Alterations in cholesterol metabolism as a risk factor for develo** Alzheimer's disease: Potential novel targets for treatment
Alzheimer's disease (AD) is the most common form of dementia and it is characterized by the
deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. However, the …
deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. However, the …
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic …
The first randomized controlled data from cardiovascular outcomes trials with proprotein
convertase subtilisin/kexin type 9 (PCSK9) inhibitors have now been reported. 1, 2 This …
convertase subtilisin/kexin type 9 (PCSK9) inhibitors have now been reported. 1, 2 This …
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management,
multidisciplinary teamwork, involvement of primary care practitioners, patient networks …
multidisciplinary teamwork, involvement of primary care practitioners, patient networks …
How low to go with glucose, cholesterol, and blood pressure in primary prevention of CVD
Diabetes, hyperlipidemia, and hypertension are modifiable risk factors that predict
cardiovascular disease events. The effect of these risk factors on incident cardiovascular …
cardiovascular disease events. The effect of these risk factors on incident cardiovascular …
LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in the United
States. Elevated low-density lipoprotein cholesterol (LDL-C) is a major causal risk factor for …
States. Elevated low-density lipoprotein cholesterol (LDL-C) is a major causal risk factor for …
The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019
J Zheng, J Wang, Y Zhang, J **
atherosclerotic cardiovascular disease. Individuals with genetic conditions associated with …
atherosclerotic cardiovascular disease. Individuals with genetic conditions associated with …